Skip to main content
IDYA logo

IDYA · IDEAYA Biosciences, Inc. · Proposed Sales

Track IDYA — free
$25.56 -0.61 (-2.33%) At close · Nov 20 Q4 2021 earnings call transcript
Market Cap
$2.47B
Shares
96.69M
Volume · Nov 20 1.11M Avg daily vol (3M) 932.53K

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2024-08-26 Jason Throne 75,000
2024-05-29 Michael White 28,500
2024-05-14 YUJIRO HATA 175,000
2024-02-09 Andres Ruiz Briseno 14,867
2024-02-01 YUJIRO HATA 100,000
2024-01-12 Andres Ruiz Briseno 4,000
2024-01-12 YUJIRO HATA 75,000
2023-12-27 Paul Stone 55,680
2023-12-15 Jason Throne 10,000
2023-12-15 YUJIRO HATA 75,000
2023-12-14 Andres Ruiz Briseno 2,000
2023-12-11 Paul Stone 44,875
2023-12-04 Paul Stone 42,964
2023-11-28 Paul Stone 39,450
2023-11-27 Paul Stone 46,654
2023-09-01 Jason Throne 20,000
2023-08-09 Paul Stone 12,500
2023-07-10 Jason Throne 14,485
2023-05-22 Jason Throne 4,485
Showing 1–19 of 19 filings
Key facts CIK 1676725 CUSIP 45166A102 13F (30d) 297 filings 263 filers Visit website Investor relations